1. Home
  2. TRIN vs AMPH Comparison

TRIN vs AMPH Comparison

Compare TRIN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIN
  • AMPH
  • Stock Information
  • Founded
  • TRIN 2007
  • AMPH 1996
  • Country
  • TRIN United States
  • AMPH United States
  • Employees
  • TRIN N/A
  • AMPH N/A
  • Industry
  • TRIN Finance/Investors Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRIN Finance
  • AMPH Health Care
  • Exchange
  • TRIN Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • TRIN 1.2B
  • AMPH 1.2B
  • IPO Year
  • TRIN 2021
  • AMPH 2014
  • Fundamental
  • Price
  • TRIN $15.22
  • AMPH $24.18
  • Analyst Decision
  • TRIN Buy
  • AMPH Buy
  • Analyst Count
  • TRIN 4
  • AMPH 6
  • Target Price
  • TRIN $15.63
  • AMPH $35.50
  • AVG Volume (30 Days)
  • TRIN 812.9K
  • AMPH 341.8K
  • Earning Date
  • TRIN 11-05-2025
  • AMPH 11-06-2025
  • Dividend Yield
  • TRIN 13.40%
  • AMPH N/A
  • EPS Growth
  • TRIN 32.58
  • AMPH N/A
  • EPS
  • TRIN 2.25
  • AMPH 2.68
  • Revenue
  • TRIN $254,887,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • TRIN $27.19
  • AMPH $1.00
  • Revenue Next Year
  • TRIN $8.97
  • AMPH $6.74
  • P/E Ratio
  • TRIN $6.77
  • AMPH $9.02
  • Revenue Growth
  • TRIN 33.44
  • AMPH 1.37
  • 52 Week Low
  • TRIN $12.50
  • AMPH $20.39
  • 52 Week High
  • TRIN $16.82
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • TRIN 51.29
  • AMPH 39.89
  • Support Level
  • TRIN $14.72
  • AMPH $22.94
  • Resistance Level
  • TRIN $15.15
  • AMPH $24.87
  • Average True Range (ATR)
  • TRIN 0.28
  • AMPH 0.83
  • MACD
  • TRIN 0.07
  • AMPH 0.11
  • Stochastic Oscillator
  • TRIN 83.67
  • AMPH 39.94

About TRIN Trinity Capital Inc.

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: